Moreover, the rise in serum FGF23 occurred in the complete absence of hyperphosphatemia in 5/6-Nx mice on either ND or CPD, further corroborating the notion that the early increase in FGF23 in CKD patients occurs independent of hyperphosphatemia and elevated PTH6. This evidence concerns the gene FGF23 and hyperphosphatemia.